Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
A microdose lithium formulation could halt signs of Alzheimer's pathology

A microdose lithium formulation could halt signs of Alzheimer's pathology

Living near major roads linked to higher incidence of neurological disorders

Living near major roads linked to higher incidence of neurological disorders

Reelin can reverse the main pathological processes associated with Alzheimer's, other tauopathies

Reelin can reverse the main pathological processes associated with Alzheimer's, other tauopathies

Young blacks, Latinos less likely than white people to have poor outcomes after bleeding stroke

Young blacks, Latinos less likely than white people to have poor outcomes after bleeding stroke

A new book on antioxidant foods that prevent or treat chronic diseases

A new book on antioxidant foods that prevent or treat chronic diseases

Case Western researchers suggest potential Alzheimer's breakthrough

Case Western researchers suggest potential Alzheimer's breakthrough

Study shows how gene therapy may help protect against vision loss in multiple sclerosis

Study shows how gene therapy may help protect against vision loss in multiple sclerosis

Diagnosed with dementia, she documented her wishes. They said no.

Diagnosed with dementia, she documented her wishes. They said no.

Antipsychotics linked to higher risk of head, brain injuries among persons with Alzheimer's

Antipsychotics linked to higher risk of head, brain injuries among persons with Alzheimer's

What the 2020s have in store for aging boomers

What the 2020s have in store for aging boomers

First randomized clinical trial finds no harm from population screening for dementia

First randomized clinical trial finds no harm from population screening for dementia

Alcohol dependence results in remodeling of functional architecture in rodent’s brain

Alcohol dependence results in remodeling of functional architecture in rodent’s brain

New tool could speed up neuroscience research into pheromones

New tool could speed up neuroscience research into pheromones

Discovery could lead to new treatments for hypertension, dementia

Discovery could lead to new treatments for hypertension, dementia

A protein found in ovarian cancer may contribute to neurodegeneration in Alzheimer's disease

A protein found in ovarian cancer may contribute to neurodegeneration in Alzheimer's disease

A molecular switch for repairing damage in central nervous system disorders discovered

A molecular switch for repairing damage in central nervous system disorders discovered

A class of antibiotics could be potential treatment for frontotemporal dementia

A class of antibiotics could be potential treatment for frontotemporal dementia

Missing a key protein in the brain can cause autism-like behaviors

Missing a key protein in the brain can cause autism-like behaviors

Researchers to examine biomarkers, economic factors that may increase risk for Alzheimer’s

Researchers to examine biomarkers, economic factors that may increase risk for Alzheimer’s

Boosting the number of neurons improves learning and memory of old mice

Boosting the number of neurons improves learning and memory of old mice

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.